SCHEMBL21187285

SCHEMBL21187285

Cc1nccc(N[C@H]2CC[C@@H](Oc3cc(N4CCOCC4)cc4ncnc(C)c34)CC2)n1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 1/20 0.38
SYK P43405 4/20 0.37
PDE10A Q9Y233 3/20 0.37
TBK1 Q9UHD2 3/20 0.37
IKBKE Q14164 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
GPR6 P46095 1/20 0.35
IRAK4 Q9NWZ3 3/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
JAK3 P52333 1/20 0.35
PRKDC P78527 2/20 0.34
TTK P33981 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21187293 0.91 PIK3CD (0.37) PIK3C3SYKPDE10ATBK1IKBKE
SCHEMBL21178651 0.91 PIK3CD (0.37) PIK3C3SYKPDE10ATBK1IKBKE
SCHEMBL30823294 0.91 PIK3CD (0.37) PIK3C3SYKPDE10ATBK1IKBKE
SCHEMBL21187365 0.91 PIK3C3 (0.38) PIK3C3SYKPDE10ATBK1IKBKE
SCHEMBL30823273 0.91 PIK3C3 (0.38) PIK3C3SYKPDE10ATBK1IKBKE
SCHEMBL21177873 0.91 PIK3C3 (0.38) PIK3C3SYKPDE10ATBK1IKBKE
SCHEMBL21177867 0.90 TBK1 (0.41) TBK1IKBKEIRAK4JAK2JAK1
SCHEMBL30823317 0.90 TBK1 (0.41) TBK1IKBKEIRAK4JAK2JAK1
SCHEMBL22651978 0.90 TBK1 (0.41) TBK1IKBKEIRAK4JAK2JAK1
SCHEMBL22635848 0.87 IRAK4 (0.38) PIK3C3SYKPDE10ATBK1IKBKE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019143678-A1 DNA-PK INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2019-07-25 WO disclosed